Skip to main content
Have a personal or library account? Click to login
Anacardic acid, a histone acetyltransferase inhibitor, stimulates hemolysis and eryptosis through energy depletion and calcium accumulation Cover

Anacardic acid, a histone acetyltransferase inhibitor, stimulates hemolysis and eryptosis through energy depletion and calcium accumulation

Open Access
|Sep 2026

References

  1. Y. Ding, Z. Ding, J. Xu, Y. Li and M. Chen, Pharmacological activities of ginkgolic acids in relation to autophagy, Pharmaceuticals (Basel) 15(12) (2022) Article ID 1469 (20 pages); https://doi:10.3390/ph15121469
  2. I. Fukuda, A. Ito, G. Hirai, S. Nishimura, H. Kawasaki, H. Saitoh, K. Kimura, M. Sodeoka and M. Yoshida, Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate, Chem. Biol. 16(2) (2009) 133–140; https://doi:10.1016/j.chembiol.2009.01.009
  3. J. Tan, B. Chen, L. He, Y. Tang, Z. Jiang, G. Yin, J. Wang and X. Jiang, Anacardic acid (6-pentadecylsalicylic acid) induces apoptosis of prostate cancer cells through inhibition of androgen receptor and activation of p53 signaling, Chin. J. Cancer Res. 24(4) (2012) 275–283; https://doi:10.3978/j.issn.1000-9604.2012.10.07
  4. J. Tan, X. Jiang, G. Yin, L. He, J. Liu, Z. Long, Z. Jiang and K. Yao, Anacardic acid induces cell apoptosis of prostatic cancer through autophagy by ER stress/DAPK3/Akt signaling pathway, Oncol. Rep. 38(3) (2017) 1373–1382; https://doi:10.3892/or.2017.5841
  5. S. Sukumari-Ramesh, N. Singh, M. A. Jensen, K. M. Dhandapani and J. R. Vender, Anacardic acid induces caspase-independent apoptosis and radiosensitizes pituitary adenoma cells, J. Neurosurg. 114(6) (2011) 1681–1690; https://doi:10.3171/2010.12.JNS10588
  6. H. Huang, X. Hua, N. Liu, X. Li, S. Liu, X. Chen, C. Zhao, X.Lan, C. Yang, Q. P. Dou and J. Liu, Anacardic acid induces cell apoptosis associated with induction of ATF4-dependent endoplasmic reticulum stress, Toxicol. Lett. 228(3) (2014) 170–178; https://doi:10.1016/j.toxlet.2014.05.012
  7. Y. A. Seong, P. G. Shin and G. D. Kim, Anacardic acid induces mitochondrial-mediated apoptosis in the A549 human lung adenocarcinoma cells, Int. J. Oncol. 42(3) (2013) 1045–1051; https://doi:10.3892/ijo.2013.1763
  8. B. Sung, M. K. Pandey, K. S. Ahn, T. Yi , M. M. Chaturvedi, M. Liu and B. Aggarwal, Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaB alpha kinase, leading to potentiation of apoptosis, Blood 111(10) (2008) 4880–4891; https://doi:10.1182/blood-2007-10-117994
  9. M. Kusio-Kobialka, W. Dudka-Ruszkowska, M. Ghizzoni, F. J. Dekker and K. Piwocka, Inhibition of PCAF by anacardic acid derivative leads to apoptosis and breaks resistance to DNA damage in BCR-ABL-expressing cells, Anticancer Agents Med Chem . 13(5) (2013) 762–767; https://doi:10.2174/1871520611313050010
  10. M. Park, D. Upton, M. Blackmon, V. Dixon, S. Craver, D. Neal and D. Perkins, Anacardic acid inhibits pancreatic cancer cell growth, and potentiates chemotherapeutic effect by Chmp1A - ATM - p53 signaling pathway, BMC Complement. Altern. Med. 18(1) (2018) Article ID 71 (10 pages); https://doi:10.1186/s12906-018-2139-3
  11. M. Harsha Raj, B. Yashaswini, J. Rössler and B. P. Salimath, Combinatorial treatment with anacardic acid followed by TRAIL augments induction of apoptosis in TRAIL resistant cancer cells by the regulation of p53, MAPK and NFκβ pathways, Apoptosis 21(5) (2016) 578–593; https://doi:10.1007/s10495-016-1223-8
  12. P. Tomasiak, J. Janisiak, D. Rogińska, M. Perużyńska, B. Machaliński and M. Tarnowski, Garcinol and anacardic acid, natural inhibitors of histone acetyltransferases, inhibit rhabdomyosarcoma growth and proliferatio, Molecules 28(14) (2023) Article ID 5292 (15 pages); https://doi:10.3390/molecules28145292
  13. Y. L. Xiu, Y. Zhao, W. F. Gou, S. Chen, Y. Takano and H. C. Zheng, Anacardic acid enhances the proliferation of human ovarian cancer cells, PLoS One 9(6) (2014) e99361 (9 pages); https://doi.org/10.1371/journal.pone.0099361
  14. R. Bissinger, A. A. M. Bhuyan, S. M. Qadri and F. Lang, Oxidative stress, eryptosis and anemia: A pivotal mechanistic nexus in systemic diseases, FEBS J. 286(5) (2019) 826–854; https://doi:10.1111/febs.14606
  15. F. Lang, E. Lang and M. Föller, Physiology and pathophysiology of eryptosis, Transfus Med. He-mother. 39(5) (2012) 308–314; https://doi:10.1159/000342534
  16. S. A. Alghareeb, M. A. Alfhili and S. Fatima, Molecular mechanisms and pathophysiological significance of eryptosis, Int. J. Mol. Sci. 24(6) (2023) Article ID 5079 (21 pages); https://doi:10.3390/ijms24065079
  17. C. Madeddu, M. Neri, E. Sanna, S. Oppi and A. Macciò, Experimental drugs for chemotherapyand cancer-related anemia, J. Exp. Pharmacol. 13 (2021) 593–611; https://doi:10.2147/JEP.S262349
  18. T. Yuan, Q. Jia, B. Zhu, D. Chen and H. Long, Synergistic immunotherapy targeting cancer-associated anemia: Prospects of a combination strategy, Cell Commun. Signal. 21(1) (2023) Article ID 117 (14 pages); https://doi:10.1186/s12964-023-01145-w
  19. A. Tkachenko, M. A. Alfhili, J. Alsughayyir, A. Attanzio, A. Al Mamun Bhuyan, B. Bukowska, A. Cilla, M. A. Quintanar-Escorza, M. Föller, O. Havranek, K. Jilani, A. Onishchenko, E. Pretorius, V. Prokopiuk, I. Restivo, L. Tesoriere, G. M. Virzì and T. Wieder, Current understanding of eryptosis: Mechanisms, physiological functions, role in disease, pharmacological applications, and nomenclature recommendations, Cell Death Dis. 16(1) (2025) Article ID 467 (36 pages); https://doi:10.1038/s41419-025-07784-w
  20. S. A. Alghareeb, J. Alsughayyir and M. A. Alfhili, Ginsenoside Rh2 regulates the calcium/ROS/ CK1α/MLKL pathway to promote premature eryptosis and hemolysis in red blood cells, Toxicol. Pathol. 52(5) (2024) 284–294; https://doi:10.1177/01926233241268846
  21. M. A. Alfhili, H. S. Alamri, J. Alsughayyir and A. M. Basudan, Induction of hemolysis and eryptosis by occupational pollutant nickel chloride is mediated through calcium influx and p38 MAP kinase signaling, Int. J. Occup. Med. Environ. Health 35(1) (2022) 1–11; https://doi:10.13075/ijomeh.1896.01814
  22. M. A. Alfhili and J. Alsughayyir, Bufalin reprograms erythrocyte lifespan through p38 MAPK and Rac1 GTPase, Toxicon 240 (2024) Article ID 107636; https://doi:10.1016/j.toxicon.2024.107636
  23. K. Tishkowski and M. Zubair, Erythrocyte Sedimentation Rate, StatPearls Publishers, Treasure Island (FL), January 2026; https://www.ncbi.nlm.nih.gov/books/NBK557485
  24. A. K. L. Cheung, A. K. L. Yang, B. H. Ngai, S. S.C. Yu, M. Gao, P. M. Lau and S. K. Kong, Quantitative detection of eryptosis in human erythrocytes using tunable resistive pulse sensing and annexin-V-beads, Analyst 140(4) (2015) 1337–1348; https://doi:10.1039/c4an02079k
  25. E. Pretorius, J. N. du Plooy and J. Bester J. A, Comprehensive review on eryptosis, Cell Physiol. Biochem. 39(5) (2016) 1977–2000; https://doi:10.1159/000447895
  26. M. Huang, J. Huang, Y. Zheng and Q. Sun, Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism, Eur. J. Med. Chem. 178 (2019) 259–286; https:lldoi:10.1016/j.ejmech.2019.05.078
  27. E. Lang, R. Bissinger, S. M. Qadri and F. Lang, Suicidal death of erythrocytes in cancer and its chemotherapy: A potential target in the treatment of tumor-associated anemia, Int. J. Cancer 141(8) (2017) 1522–1528; https://doi:10.1002/ijc.30800
  28. J. M. Rifkind and E. Nagababu, Hemoglobin redox reactions and red blood cell aging, Antioxid. Redox Signal. 18(17) (2013) 2274–2283; https://doi:10.1089/ars.2012.4867
  29. A. I. Alayash, Mechanisms of toxicity and modulation of hemoglobin-based oxygen carriers, Shock 52(1S Suppl 1) (2019) 41–49; https://doi:10.1097/SHK.0000000000001044
  30. M. T. Bozza and V. Jeney, Pro-inflammatory actions of heme and other hemoglobin-derived DAMPs, Front. Immunol. 11 (2020) Article ID 1323 (13 pages); https://doi:10.3389/fimmu.2020.01323
  31. E. Pretorius, Erythrocyte deformability and eryptosis during inflammation, and impaired blood rheology, Clin. Hemorheol. Microcirc. 69(4) (2018) 545–550; https://doi:10.3233/CH-189205
  32. S. K. Jha and S. Vaqar, Hereditary Elliptocytosis, StatPearls Publishers, Treasure Island (FL), January 2026; https://www.ncbi.nlm.nih.gov/books/NBK562333
  33. P. Pattanayak and K. Sethy, Antioxidant profile of anacardic acid derivatives and their effects on oxidative stress-induced diseases: An update, Russ. J. Bioorg. Chem. 51(5) (2025) 2247–2260; https://doi:10.1134/S1068162025600400
  34. A. Kondratskyi, K. Kondratska, R. Skryma, D. J. Klionsky and N. Prevarskaya, Ion channels in the regulation of autophagy, Autophagy 14(1) (2018) 3–21; https://doi:10.1080/15548627.2017.1384887
  35. B. Kalyanaraman, J. Joseph, S. Kalivendi, S. Wang, E. Konorev and S. Kotamraju. Doxorubicin-induced apo ptosis: Implications in cardiotoxicity, Mol. Cell Biochem. 234–235(1–2) (2002) 119–124; https://doi.org/10.1023/A:1015976430790
  36. Q. Jin, C. Yao, Y. Bian and J. Pi, Pb-induced eryptosis may provoke thrombosis prior to hemolysis, Int. J. Mol. Sci. 23(13) (2022) Article ID 7008 (13 pages); https://doi:10.3390/ijms23137008
  37. T. Peter, R. Bissinger, E. Signoretto, A. F. Mack and F. Lang, Micafungin-induced suicidal erythrocyte death, Physiol. Biochem. 39(2) (2016) 584–595; https://doi:10.1159/000445650
  38. D. Z. de Back, E. B. Kostova, M. van Kraaij, T. K. van den Berg and R. van Bruggen, Of macrophages and red blood cells; a complex love story, Front. Physiol. 5 (2014); https://doi:10.3389/fphys.2014.00009
  39. S. Kurmangaliyeva, K. Baktikulova, A. Tkachenko, B. Seitkhanova, L. Tryfonyuk, F. Rakhimzhanova, R. Yussupov and K. Kurmangaliyev, Eryptosis in liver diseases: Contribution to anemia and hypercoagulation, Med. Sci. (Basel) 13(3) (2025) Article ID 125 (22 pages); https://doi:10.3390/medsci13030125
  40. B. N. Radde, N. Alizadeh-Rad, S. M. Price, D. J. Schultz and C. M. Klinge, Anacardic acid, salicylic acid, and oleic acid differentially alter cellular bioenergetic function in breast cancer cells, J. Cell. Biochem. 117(11) (2016) 2521–2532; https://doi:10.1002/jcb.25544
  41. J. P. Nicolay, G. Liebig, O. M. Niemoeller, S. Koka, M. Ghashghaeinia, T. Wieder, J. Haendeler, R. Busse and F. Lang, Inhibition of suicidal erythrocyte death by nitric oxide, Pflugers Arch. 456(2) (2008) 293–305; https://doi:10.1007/s00424-007-0393-1
  42. O. M. Niemoeller, P. J. Bentzen, E. Lang and F. Lang, Adenosine protects against suicidal erythrocyte death, Pflugers Arch. 454(3) (2007) 427–439; https://doi:10.1007/s00424-007-0218-2
  43. C. Boulet, C. D. Doerig and T. G. Carvalho, Manipulating eryptosis of human red blood cells: A novel antimalarial strategy?, Front. Cell. Infect. Microbiol. 8 (2018) Article ID 419 (18 pages); https://doi:10.3389/fcimb.2018.00419
  44. L. Tyagi, U. Kumar, S. Mishra, Simran, G. Rathi and D. Parashar, Epigenetic analysis in cancer research, Methods Cell. Biol. 198 (2025) 135–172; https://doi:10.1016/bs.mcb.2025.02.021
DOI: https://doi.org/10.2478/acph-2026-0026 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Accepted on: Sep 7, 2026
Published on: Sep 23, 2026
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2026 Sara Y. Aldeghaither, Mohammad A. Alfhili, Jawaher Alsughayyir, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.